Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience

Introduction: Well-differentiated neuroendocrine tumors of the appendix (A-WDNET) are the most common neoplasms of the appendix but are rare and incidental. INSM1 is a novel transcription factor marker with high sensitivity and specificity for neuroendocrine differentiation. It may display architect...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Koyuncuer, Tolga Canbak, Aylin Acar, Onur Şahin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-04-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpm.ijpm_514_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825205530601193472
author Ali Koyuncuer
Tolga Canbak
Aylin Acar
Onur Şahin
author_facet Ali Koyuncuer
Tolga Canbak
Aylin Acar
Onur Şahin
author_sort Ali Koyuncuer
collection DOAJ
description Introduction: Well-differentiated neuroendocrine tumors of the appendix (A-WDNET) are the most common neoplasms of the appendix but are rare and incidental. INSM1 is a novel transcription factor marker with high sensitivity and specificity for neuroendocrine differentiation. It may display architecturally diverse tumor growth patterns including solid, nest, insular trabecular, and acinar. Aims: The aim of this study was to determine the staining expression of INSM1 in A-WDNETs and detail the morphological tumor growth patterns. Materials and Methods: INSM1 immunohistochemistry was performed on 35 A-WDNET patients. Tumors were histologically classified according to their growth patterns. Results: Thirty-five patients, 60% of whom were male, had a mean age of 30 years at diagnosis and a mean tumor size of 0.9 cm. Eight percent of the tumors invaded the mucosa/submucosa, 34.3% showed invasion into the muscularis propria, 57.1% showed invasion into the subserosa or mesoappendix, LN metastasis was observed in two patients, lymph-vascular invasion in two patients, and perineural invasion in five patients. Ninety-four percent of the tumors were grade 1, the mitotic rate was >2% in two cases, and Ki-67 PI was >3% in two cases. INSM1 was positive in all cases (100%), 1+ 8.6%, 2+ 5.7%, 3+ 17.1%, 4+ 68.6%, weak staining in 11.4%, moderate staining in 22.9%, and strong staining in 67.7%. Type A histological growth pattern was observed in 54.3%, type B in 31.4%, and type C in 14.3% architecturally. Conclusions: INSM1 was positive in all A-WDNET morphological patterns and was 100% sensitive. INSM1 IHC can be used as an alternative to traditional neuroendocrine markers or in combination with the diagnosis of neuroendocrine tumors.
format Article
id doaj-art-249d59e163fc41ee9bec7b0a320c0c35
institution Kabale University
issn 0377-4929
0974-5130
language English
publishDate 2024-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj-art-249d59e163fc41ee9bec7b0a320c0c352025-02-07T13:56:08ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49290974-51302024-04-0167228228810.4103/ijpm.ijpm_514_23Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experienceAli KoyuncuerTolga CanbakAylin AcarOnur ŞahinIntroduction: Well-differentiated neuroendocrine tumors of the appendix (A-WDNET) are the most common neoplasms of the appendix but are rare and incidental. INSM1 is a novel transcription factor marker with high sensitivity and specificity for neuroendocrine differentiation. It may display architecturally diverse tumor growth patterns including solid, nest, insular trabecular, and acinar. Aims: The aim of this study was to determine the staining expression of INSM1 in A-WDNETs and detail the morphological tumor growth patterns. Materials and Methods: INSM1 immunohistochemistry was performed on 35 A-WDNET patients. Tumors were histologically classified according to their growth patterns. Results: Thirty-five patients, 60% of whom were male, had a mean age of 30 years at diagnosis and a mean tumor size of 0.9 cm. Eight percent of the tumors invaded the mucosa/submucosa, 34.3% showed invasion into the muscularis propria, 57.1% showed invasion into the subserosa or mesoappendix, LN metastasis was observed in two patients, lymph-vascular invasion in two patients, and perineural invasion in five patients. Ninety-four percent of the tumors were grade 1, the mitotic rate was >2% in two cases, and Ki-67 PI was >3% in two cases. INSM1 was positive in all cases (100%), 1+ 8.6%, 2+ 5.7%, 3+ 17.1%, 4+ 68.6%, weak staining in 11.4%, moderate staining in 22.9%, and strong staining in 67.7%. Type A histological growth pattern was observed in 54.3%, type B in 31.4%, and type C in 14.3% architecturally. Conclusions: INSM1 was positive in all A-WDNET morphological patterns and was 100% sensitive. INSM1 IHC can be used as an alternative to traditional neuroendocrine markers or in combination with the diagnosis of neuroendocrine tumors.https://journals.lww.com/10.4103/ijpm.ijpm_514_23appendicealgradehistomorphologyinsm1neuroendocrine tumors
spellingShingle Ali Koyuncuer
Tolga Canbak
Aylin Acar
Onur Şahin
Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
Indian Journal of Pathology and Microbiology
appendiceal
grade
histomorphology
insm1
neuroendocrine tumors
title Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
title_full Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
title_fullStr Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
title_full_unstemmed Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
title_short Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
title_sort evaluation of immunohistochemical expression of novel neuroendocrine marker insm1 and histological tumor growth pattern in well differentiated neuroendocrine tumors of the appendix 15 year single tertiary center experience
topic appendiceal
grade
histomorphology
insm1
neuroendocrine tumors
url https://journals.lww.com/10.4103/ijpm.ijpm_514_23
work_keys_str_mv AT alikoyuncuer evaluationofimmunohistochemicalexpressionofnovelneuroendocrinemarkerinsm1andhistologicaltumorgrowthpatterninwelldifferentiatedneuroendocrinetumorsoftheappendix15yearsingletertiarycenterexperience
AT tolgacanbak evaluationofimmunohistochemicalexpressionofnovelneuroendocrinemarkerinsm1andhistologicaltumorgrowthpatterninwelldifferentiatedneuroendocrinetumorsoftheappendix15yearsingletertiarycenterexperience
AT aylinacar evaluationofimmunohistochemicalexpressionofnovelneuroendocrinemarkerinsm1andhistologicaltumorgrowthpatterninwelldifferentiatedneuroendocrinetumorsoftheappendix15yearsingletertiarycenterexperience
AT onursahin evaluationofimmunohistochemicalexpressionofnovelneuroendocrinemarkerinsm1andhistologicaltumorgrowthpatterninwelldifferentiatedneuroendocrinetumorsoftheappendix15yearsingletertiarycenterexperience